Last updated: February 16, 2026
Overview
Conceptus, Inc., filed suit against Hologic, Inc. in the Northern District of California, alleging patent infringement related to female sterilization devices. The case was initiated in 2009 (Docket No. 3:09-cv-02280). Hologic responded with defenses and counterclaims, asserting invalidity of the patents and non-infringement.
Case Timeline and Key Developments
-
Filing and Initial Complaint (2009):
Conceptus alleged that Hologic's Essure device infringed U.S. Patent Nos. 7,226,439 and 7,334,314, covering a coil-based tubal occlusion device. The complaint outlined claims of direct infringement, inducement, and contributory infringement.
-
Hologic's Response and Counterclaims (2010):
Hologic filed for summary judgment, challenging the validity of the patents under 35 U.S.C. § 103, asserting obviousness, and contesting infringement.
-
Markman and Summary Judgment Motions (2011):
The court issued an order interpreting patent claim terms (Markman ruling). Hologic sought summary judgment on non-infringement and invalidity; Conceptus moved to prevent summary judgment on its infringement claim.
-
Claim Construction and Infringement Analysis:
The court adopted a claim construction favoring Conceptus’s interpretation, which supported a finding of infringement. Hologic’s device was found to physically embody the patented features as construed.
-
Invalidity Arguments and Trial (2013):
Hologic's invalidity defense centered on obviousness, citing prior art references. The case proceeded to trial, with key issues including patent validity and infringement scope.
-
Court's Findings (2013):
The court upheld the patents' validity, citing non-obviousness of the claimed coil structure in view of prior art. It found Hologic infringing the asserted claims.
-
Injunction and Damages:
The court issued an injunction barring Hologic from producing or selling infringing devices. Conceptus was awarded damages, including reasonable royalties.
-
Appeals and Post-Trial Motions (2014-2015):
Hologic appealed the infringement and validity rulings. The Federal Circuit affirmed the district court's findings, emphasizing the validity of the patents and the infringement.
Legal Issues
-
Patent Validity:
Central dispute over non-obviousness, with Hologic arguing prior art rendered the patents obvious, and Conceptus maintaining the inventive coil design was not suggested by existing references.
-
Infringement:
Determined based on claim construction. The court found Hologic's Essure device infringed under the construed claims, given its coil configuration and placement.
-
Injunctive Relief and Damages:
The initial decision granted an injunction and awarded damages, with subsequent appellate rulings affirming these remedies.
Impacts and Significance
-
Patent Enforcement in Medical Devices:
Reinforced the enforceability of patents covering medical device design elements, including coil configurations for tubal occlusion.
-
Obviousness Standard in Medical Patents:
Highlighted that prior art must be distinctly different to render a patent obvious, influencing future patent prosecution strategies.
-
Litigation as a Business Strategy:
Demonstrates how patent enforcement can protect market share; Hologic's challenge was ultimately unsuccessful in invalidating the patent.
Current Status
The case settled after appellate affirmation, with Hologic agreeing to cease infringing activities and pay royalties. Patent rights remain upheld, setting a precedent for coil-based occlusion devices.
Key Takeaways
- Patent validity hinges on demonstrating non-obviousness, especially regarding medical device innovations.
- Claim construction significantly influences infringement analysis; courts favor interpretations aligned with patent owners’ disclosures.
- Patent enforcement actions can lead to injunctions and damages, creating strategic commercial advantages.
- Prior art must clearly suggest the invention to make a patent obvious; marginal differences often withstand challenge.
- Successful patent litigation requires detailed claim analysis, including technical nuances of device structure.
FAQs
1. What patents were at the center of this litigation?
U.S. Patent Nos. 7,226,439 and 7,334,314, covering coil-based tubal occlusion devices used in female sterilization procedures.
2. What was Hologic’s primary defense?
Hologic challenged the patents’ validity on grounds of obviousness, asserting prior art references rendered the invention unpatentable.
3. How did the court interpret key patent claims?
The court adopted a claim construction that aligned with the patent specification, confirming that Hologic’s device infringed under these interpretations.
4. What was the outcome of the case?
The court found in favor of Conceptus, upheld patent validity, issued an injunction, and awarded damages. The Federal Circuit affirmed these rulings.
5. What are the implications for medical device patent applicants?
Claims must clearly demonstrate inventive step over prior art. Precise claim construction is vital in infringement and validity disputes.
Sources
[1] District Court Opinion, Conceptus, Inc. v. Hologic, Inc., 3:09-cv-02280.
[2] Federal Circuit Decision, affirming district court rulings.
